Veritas Pharma Provides Comment on Canadian Senate Recommendation for a One-Year Deferment Legalizing Cannabis
10 mai 2018 03h10 HE
|
Veritas Pharma Inc.
VANCOUVER, British Columbia, May 10, 2018 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt:2VP), (“Veritas” or the “Company”) provides the following statement to the...
Veritas Pharma Establishes New Subsidiary in Puerto Rico, USA
07 mai 2018 03h10 HE
|
Veritas Pharma Inc.
VANCOUVER, British Columbia, May 07, 2018 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt:2VP), (“Veritas” or the “Company”) is pleased to announce the establishment of new...
Dr. Michael K. Pugsley Joins Veritas Pharma’s Advisory Board
18 avr. 2018 03h50 HE
|
Veritas Pharma Inc.
VANCOUVER, British Columbia, April 18, 2018 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt:2VP), (“Veritas” or the “Company”) is pleased to announce that Dr. Michael K....
Veritas Pharma Completes the 100% Takeover of Cannevert Therapeutics
21 mars 2018 03h15 HE
|
Veritas Pharma Inc.
VANCOUVER, British Columbia, March 21, 2018 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt:2VP) (“Veritas” or the “Company”) is pleased to announce the Company has...
Veritas Pharma Signs Letter of Intent with 3 Carbon Extractions Inc.
08 mars 2018 03h10 HE
|
Veritas Pharma Inc.
VANCOUVER, British Columbia, March 08, 2018 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt:2VP) (“Veritas” or the “Company”) is pleased to announce the signing of a...
Veritas Pharma Signs Memorandum of Understanding with BioCan Technologies
28 févr. 2018 03h05 HE
|
Veritas Pharma Inc.
VANCOUVER, British Columbia, Feb. 28, 2018 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt:2VP) (“Veritas” or the “Company”) is pleased to announce that it has entered into...
Veritas Pharma Provides Corporate Update on Q1 2018
21 févr. 2018 03h10 HE
|
Veritas Pharma Inc.
VANCOUVER, British Columbia, Feb. 21, 2018 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt:2VP), (“Veritas” or the “Company”) is pleased to provide an official corporate...
Veritas Intends to Complete the 100% Takeover of Cannevert Therapeutics in Q1
20 févr. 2018 03h10 HE
|
Veritas Pharma Inc.
VANCOUVER, British Columbia, Feb. 20, 2018 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt:2VP), (“Veritas” or the “Company”) is pleased to announce the Company and its...
Veritas’ Research Arm Cannevert Signs Clinical Research Agreement for Human Studies to Assess its Lead Cannabis Strain for Pain
10 janv. 2018 17h02 HE
|
Veritas Pharma Inc.
VANCOUVER, British Columbia, Jan. 10, 2018 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt:2VP), (“Veritas” or the “Company”) is pleased to announce that its research arm,...
Veritas and Cannevert Complete Prestudy Visit of the Puerto Rico Clinical Trial Facility
29 déc. 2017 03h05 HE
|
Veritas Pharma Inc.
VANCOUVER, British Columbia, Dec. 29, 2017 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt:2VP), (“Veritas” or the “Company”) announces that it has completed a prestudy...